Minted: - / 5000

4462 Intepirdine
8e1e5b635a8d5bfab3fe4ad0076a84caf5c846a76c8c7c44d05fdb07c088cc59

Properties

Background

Orange
Bottle

Pink
Cap

Green
Syringe

Red
Bubbles
No
Drops
Yes
Label
Cross

Chemistry

Formula
C19H19N3O2S
Carbon
19
Polarity
Neutral

Intepirdine (INN; developmental codes SB-742457, RVT-101) is a selective 5-HT₆ receptor antagonist with potential cognition, memory, and learning-enhancing effects. It was under development by GlaxoSmithKline for the treatment of Alzheimer's disease and demonstrated some preliminary efficacy in phase II clinical trials. GSK chose not to continue development and sold the rights to Axovant Sciences for $5 million in December 2014.

From Wikipedia, the free encyclopedia. License: CC BY-SA.